The Colorado Senate gave initial approval to a measure to create regulatory frameworks for legal psychedelics in accordance with a voter-approved initiative.
On Monday, the Senate President Steve Fenberg’s (D) legislation passed in second reading with some amendments. The final vote will be held on Tuesday. After that, the bill will move to the House of Representatives.
“This is an original proposition which was approved by voters.” Fenberg announced on the floor that we were now at the point where this was being implemented. “Whether you supported or not, it is on us to ensure its success.”
Before reaching the Senate floor, the measure passed through the Senate Finance Committee as well as the Appropriations Committee.
The bill aims to establish regulations for the psychedelics law voters approved at the ballot box last year. It focuses primarily on rules for the use of the substances in licensed centers under the supervision of facilitators. has received mixed feedback from stakeholders and advocates .
The ballot measure asked for the establishment of an advisory council that would develop regulatory recommendations in order to inform a more comprehensive legislation covering this access. But as the process continues the Senate President filed a separate law last week to set rules.
The bill aims to establish policies for “healing centres” where adults over 21 could receive psychedelic treatments, tighten rules on cultivation, and set up licensing requirements. It also outlines state agency regulatory duties and penalties for unapproved activities.
On Monday, the senators approved three amendments proposed by the sponsor.
First, people would be allowed to own up to five businesses that sell psychedelics instead of three. Second, people could be paid to provide harm reduction services or support related to the use psychedelics so long as no advertising is involved. Thirdly the juvenile court would have jurisdiction over cases in which children older than 10 are accused by authorities of breaking drug laws relating to psychedelics.
A second adopted amendment clarifies that the transfer of psychedelics or the growing more than allowed is only a crime if someone does it “knowingly”. It also removes language that says that police cannot use legal activity as a sole factor in determining reasonable suspect while maintaining the language that it cannot be used to determine probable cause. The amendment specifies that it applies to crimes committed after July 1, 2023.
Members also approved a second proposed change that would provide legal protections to people who test psychedelics.
The Senate rejected the two amendments proposed by another senator, which would have allowed local authorities to ban psychedelics business and personal cultivation.
There will be other things we need to do in order to get this right. Fenberg told the audience on Monday that “a lot of people were watching”. Most states have never done this. “It’s crucial that we do it right.”
He said that despite the fact that we may joke around, this is a serious matter. “Many people have found these medications to be extremely helpful in treating mental disorders and other problems. I am excited that Colorado has taken the lead in providing a safe, responsible way for people to get these medicines. Decriminalizing these substances is also a good idea.
The bill as amended contains the following key elements:
The bill would continue the policy that was approved by voters in the ballot measure, which allows adults over 21 to possess psilocybin (including ibogaine), mescaline, DMT, and psilocyn.
A $100 fine would be imposed on anyone who is caught using psychedelics in public or underage.
Adults would only be allowed to grow natural psychedelics in a private home, within an enclosed area that was not larger than 12 by 12 feet. This is unless the locality has a policy that allows for larger grows. A $1,000 fine would be imposed on anyone who cultivates beyond the limits.
People with previous convictions for psychedelic activities would be eligible for sealing their records.
The Department of Revenue’s new Division of Natural Medicine would be responsible for regulating therapeutic programs and issuing licenses to cultivators, manufacturers and testing facilities, as well as healing centers. This is a difference to the original initiative which gave the primary responsibilities of the Department of Regulatory Agencies.
DORA would create a federally recognized American Tribes and Indigenous Community Working Group, which was not included in the ballot initiative. This group will identify and address any unintended effects of the reform.
The law clarifies that the use of synthetic psychedelics is not allowed. Possession of psychedelics containing “hazardous substances” such as solvents is a Class 2 crime.
The bill allows for the addition of additional psychedelics to healing centers. Initially, only psilocybin or psilocyn can be used at these facilities. The bill is different from the ballot measure because regulators can authorize supervised use at healing centers at any time. They don’t have to wait until June 1, 2026 as they would for DMT and mescaline.
Four categories of licenses would exist: Healing centers, cultivation sites, product manufacturers, and testing facilities.
The bill retains the provisions of the ballot measure to prevent localities from prohibiting healing centers. However, it says that they can enact regulations governing when, where and how they operate.
The date by which regulators must begin accepting and reviewing applications for licenses will be moved from September 30th, 2024 to December 31st, 2024.
In a partial solution to the federal 280E provisions, licensed psychedelic businesses can deduct their expenses from state taxes.
Marijuana Moment tracks more than 1,000 cannabis and drug policy bills that have been introduced in state legislatures, and Congress. Patreon supporters who pledge at least $25/month gain access to our interactive charts, maps and hearing calendar.
Discover more about our marijuana bills tracker. Become a Patreon supporter to gain access.
—
The findings section of the bill notes that, “even though there is tremendous potential for using natural medicine to manage various mental health conditions and to promote healing and spiritual growth, it must be balanced against the potential health and safety hazards that could be posed to consumers, as well as cultural harms that could be imposed on indigenous and traditional communities with connections to natural medicines.”
It states that “considerable harm could occur to indigenous peoples, communities, cultures and religions, if natural medicines are overly commodified and commercialized in a way that erases important cultural and religious context.”
The deadline for passing the bill through the legislature is May 6, which is the end of the legislative session.
Early reactions to the bill have been mixed. Some supporters of the basic framework are in favor, while others oppose it because they believe that the regulations are excessive.
During a hearing in a Senate committee last week, the Senate President said that he felt that the implementation legislation “hit the right balance”.
He said, “I believe we are implementing 122 in its spirit.” “I believe we are doing it in a reasonable way to protect consumers and provide clarity for people–for both regular citizens and law enforcement as they proceed down this road.”
In Colorado, on Monday the governor announced that the state will launch a loan program for social equity marijuana businesses.
New York Lawmakers Announce Joint Committee Hearing On Marijuana Banking
Photo elements are courtesy of carlosemmaskype, and Apollo.
The first time Marijuana Moment published the post Colorado Senate gives initial approval to Psychedelics Regulation Bill was on Marijuana Moment .
